Vasotec and Robitussin drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Vasotec (enalapril maleate) and Robitussin (guaifenesin). Common drug interactions include headache among females and hyperhidrosis among males.
The phase IV clinical study analyzes what interactions people have when they take Vasotec and Robitussin. It is created by eHealthMe based on reports of 12 people who take the same drugs from the FDA, and is updated regularly.
What is Vasotec?
Vasotec has active ingredients of enalapril maleate. It is often used in high blood pressure. eHealthMe is studying from 14,646 Vasotec users. Check the latest studies of Vasotec.
What is Robitussin?
Robitussin has active ingredients of guaifenesin. eHealthMe is studying from 3,532 Robitussin users. Check the latest studies of Robitussin.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
12 people who take Vasotec and Robitussin together, and have interactions are studied.

What are the common drug interactions of Vasotec and Robitussin, by gender? *:
female:
- Headache (pain in head)
- Hyperlipidaemia (presence of excess lipids in the blood)
- Hypoxia (low oxygen in tissues)
- Obesity (having too much body fat)
- Palpitations (feelings or sensations that your heart is pounding or racing)
- Peripheral vascular disorder
- Postoperative wound infection
- Pulmonary congestion (congestion in the lungs)
- Pulmonary hypertension (increase in blood pressure in the lung artery)
- Sinus tachycardia (a heart rhythm with elevated rate of impulses originating from the sinoatrial node)
male:
- Hyperhidrosis (abnormally increased sweating)
- Urinary incontinence (inability to control the flow of urine and involuntary urination)
- Cardiomegaly (increased size of heart than normal)
- Chest pain
- Cognitive disorder (mental health disorders affects learning, memory, perception, and problem solving)
- Confusional state
- Constipation
- Cough
- Decreased appetite
- Dizziness
What are the common drug interactions of Vasotec and Robitussin, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
- Pleural effusion (water on the lungs)
- Presyncope
- Pulmonary oedema (fluid accumulation in the lungs)
- Upper respiratory tract infection
- Urinary incontinence (inability to control the flow of urine and involuntary urination)
- Uterine cancer
- Vomiting
- Blood glucose increased
- Bundle branch block left (absence of transmission of electric impulses from the atrioventricular (av) bundle of his to the left ventricle)
- Fatigue (feeling of tiredness)
30-39:
n/a
40-49:
- Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
- Diabetic nephropathy (diabetic kidney disease)
- Diabetic retinopathy (damage to the retina caused by complications of diabetes)
- Type 2 diabetes mellitus
50-59:
- Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
- Diabetes mellitus inadequate control
- Diabetic autonomic neuropathy (diabetes with nerve disorder, painful muscle wasting and weakness)
- Diabetic coma
- Hyperglycaemia (high blood sugar)
60+:
- Dyspnoea (difficult or laboured respiration)
- Hyperhidrosis (abnormally increased sweating)
- Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
- Blood glucose increased
- Cardioactive drug level increased
- Cardiomegaly (increased size of heart than normal)
- Chest pain
- Cognitive disorder (mental health disorders affects learning, memory, perception, and problem solving)
- Confusional state
- Constipation
What are the existing conditions these people have? *
- Schizoaffective Disorder (a mental disorder characterized by disordered thought): 1 person, 8.33%
- Prostate Cancer: 1 person, 8.33%
- Depression: 1 person, 8.33%
- Cough: 1 person, 8.33%
* Approximation only. Some reports may have incomplete information.
Do you take Vasotec and Robitussin?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Vasotec (14,646 reports)
- Robitussin (3,532 reports)
Browse all drug interactions of Vasotec and Robitussin:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Vasotec:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Robitussin:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Vasotec and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Robitussin and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on enalapril maleate and guaifenesin (the active ingredients of Vasotec and Robitussin, respectively), and Vasotec and Robitussin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Bystolic and Simcor - 5 seconds ago
- Could Clarithromycin cause Periorbital Oedema? - 17 seconds ago
- Could Mycostatin cause Hypertransaminasaemia? - 21 seconds ago
- Could Descovy cause Heart Palpitations? - 31 seconds ago
- Could Reclast cause Vein Disorder? - 45 seconds ago
- Could Abilify cause Colonic Polyp? - 46 seconds ago
- Cosopt Pf vs. Latanoprost, side effect and effectiveness comparison - 50 seconds ago
- Drug interactions of Zofran and Cefzil - 53 seconds ago
- Could Dapagliflozin cause Hypokalemia? - a minute ago
- Could Coumadin cause Venous Occlusion? - a minute ago